The effect of puromycin on intranuclear steps in ribosome biosynthesis

Area of Science:

• Molecular Biology
• Cell Biology
• Biochemistry

Background:

• Puromycin inhibits protein synthesis and is known to affect ribosome synthesis.
• Ribosomal RNA (rRNA) synthesis, methylation, and initial processing continue despite puromycin treatment.

Purpose of the Study:

• To investigate the specific mechanism by which puromycin inhibits ribosome biogenesis.
• To differentiate the effects of protein synthesis inhibition from direct effects on rRNA processing and ribosome assembly.

Main Methods:

• Cell fractionation studies were employed to analyze RNA processing and localization.
• Puromycin and cycloheximide were used as protein synthesis inhibitors to compare their effects.

Main Results:

• Puromycin treatment leads to the degradation of the 16S rRNA moiety after initial processing of the 45S precursor.
• No mature ribosomal RNA species were observed to exit the nucleolus in the presence of puromycin.
• RNA synthesized during puromycin treatment remained functional for new ribosome assembly upon drug removal.
• Cycloheximide, another protein synthesis inhibitor, did not cause rRNA degradation and allowed new ribosome completion, alone or with puromycin.

Conclusions:

• Puromycin's inhibition of ribosome synthesis is primarily due to the degradation of rRNA precursors, not solely the inhibition of protein synthesis.
• The nucleolus is the site of initial rRNA processing, but subsequent maturation and export are blocked by puromycin.
• The observed effects are specific to puromycin's action on rRNA stability, distinct from general protein synthesis inhibition.